BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Early pregnancy factor
,
Aspirin
,
rs3825942
,
PTEN
,
T cell differentiation
,
Ischemia
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
nuclear hormone receptors
Summary
General Info
Curated Studies
Most Correlated Studies
L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
L1000 CMAP - Lung cancer A549 cells treated with ligand perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
Leydig Cell-Specific DAX1-Deleted Mice Has Higher Testosterone Level in the Testis During Pubertal D…
Dax1 modulates ERĪ±-dependent hypothalamic estrogen sensing in female mice.
Live Birth in Sex-Reversed XY Mice Lacking the Nuclear Receptor Dax1.
The Drosophila E78 nuclear receptor regulates dietary triglyceride uptake and systemic lipid levels.
Cooperation between HDAC3 and DAX1 mediates lineage restriction of embryonic stem cells.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Investigating the Metabolic Pathways in Hormone Receptor Positive/HER2 Negative Breast Cancer
Nuclear Myosin VI - a Therapeutic Target in Breast Cancer
Capecitabine in the Treatment of Breast Cancer With Low-hormone Receptor Expression After Neoadjuvan…
Hormone Replacement Therapy on the Postmenopausal Endometrium
Testing the Use of Fulvestrant and Binimetinib Targeted Treatment for NF1 Mutation in Hormone Recept…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ